Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Haloperidol Versus Low-potency First-generation Antipsychotic Drugs for Schizophrenia: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435215/all/images/tooltip-triangle.png. Accessed 14 May 2024.
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435215/all/images/tooltip-triangle.png. Accessed May 14, 2024.
Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435215/all/images/tooltip-triangle.png
Haloperidol Versus Low-potency First-generation Antipsychotic Drugs for Schizophrenia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 May 14]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435215/all/images/tooltip-triangle.png.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia: Cochrane systematic review
ID - 435215
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435215/all/images/tooltip-triangle.png
DB - Evidence Central
DP - Unbound Medicine
ER -